Shockwave Begins First All-Female Study Of Coronary Interventions

The EMPOWER CAD trial will evaluate Shockwave’s intravascular lithotripsy system in female patients undergoing a percutaneous coronary intervention for coronary artery disease. Principal investigator Alexandra Lansky spoke to Medtech Insight about the first-of-its kind study in this understudied population.

Heart Equity
• Source: Shutterstock

A new study sponsored from Shockwave Medical, which specializes in coronary intravascular lithotripsy (IVL), is designed to close the deadly gender gap in coronary artery disease (CAD).

Heart disease kills more women in the US than any other disease — a fact not even many women are aware of. In 2020, heart disease accounted for one in...

Key Takeaways
  • Heart disease kills more women in the US than any other disease, but most people underestimate the risk for women.
  • Clinical trials for cardiovascular technologies have traditionally...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Medtech Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Diversity & Inclusion

More from ESG